ProfileGDS4516 / 217133_x_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 30% 26% 30% 34% 31% 29% 35% 38% 30% 31% 27% 34% 30% 26% 37% 29% 37% 30% 27% 26% 24% 31% 30% 33% 31% 32% 29% 27% 37% 31% 36% 27% 32% 29% 33% 28% 34% 30% 33% 28% 23% 27% 27% 23% 30% 27% 31% 28% 24% 27% 26% 31% 29% 35% 31% 30% 35% 36% 27% 26% 37% 37% 29% 39% 31% 39% 27% 29% 30% 24% 38% 32% 30% 33% 28% 31% 29% 34% 27% 30% 28% 37% 32% 36% 30% 32% 38% 29% 29% 34% 35% 30% 31% 35% 26% 31% 31% 20% 35% 32% 28% 35% 31% 45% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]4.3499330
GSM537345patient 119, cancer, LCM [OPG study]4.1186826
GSM537355patient 138, cancer, LCM [OPG study]4.3540830
GSM537366patient 154, cancer, LCM [OPG study]4.5124534
GSM537370patient 022, cancer, LCM [OPG study]4.3231531
GSM537380patient 037, cancer, LCM [OPG study]4.279729
GSM537392patient 077, cancer, LCM [OPG study]4.5247135
GSM537415patient 032, cancer, LCM [OPG study]4.6592238
GSM537417patient 042, cancer, LCM [OPG study]4.4556530
GSM537422patient 059, cancer, LCM [OPG study]4.3965831
GSM537423patient 064, cancer, LCM [OPG study]4.2050827
GSM537427patient 084, cancer, LCM [OPG study]4.4753834
GSM537430patient 090, cancer, LCM [OPG study]4.3495930
GSM537336patient 107, cancer, LCM [OPG study]4.1360226
GSM537337patient 108, cancer, LCM [OPG study]4.6288737
GSM537348patient 124, cancer, LCM [OPG study]4.2676229
GSM537349patient 125, cancer, LCM [OPG study]4.6879437
GSM537356patient 139, cancer, LCM [OPG study]4.3680430
GSM537361patient 147, cancer, LCM [OPG study]4.2357927
GSM537374patient 026, cancer, LCM [OPG study]4.2070726
GSM537377patient 033, cancer, LCM [OPG study]4.1213124
GSM537378patient 034, cancer, LCM [OPG study]4.3615631
GSM537379patient 036, cancer, LCM [OPG study]4.3507430
GSM537383patient 046, cancer, LCM [OPG study]4.4605533
GSM537388patient 063, cancer, LCM [OPG study]4.3930431
GSM537395patient 082, cancer, LCM [OPG study]4.4080732
GSM537400patient 099, cancer, LCM [OPG study]4.2972729
GSM537404patient 129, cancer, LCM [OPG study]4.2605727
GSM537409patient 141, cancer, LCM [OPG study]4.6327437
GSM537418patient 044, cancer, LCM [OPG study]4.314231
GSM537425patient 070, cancer, LCM [OPG study]4.6678436
GSM537333patient 102, cancer, LCM [OPG study]4.2221927
GSM537342patient 116, cancer, LCM [OPG study]4.4441132
GSM537347patient 123, cancer, LCM [OPG study]4.3351129
GSM537350patient 127, cancer, LCM [OPG study]4.5291633
GSM537362patient 148, cancer, LCM [OPG study]4.2501528
GSM537363patient 150, cancer, LCM [OPG study]4.5140234
GSM537368patient 156, cancer, LCM [OPG study]4.3626930
GSM537376patient 031, cancer, LCM [OPG study]4.5153933
GSM537381patient 038, cancer, LCM [OPG study]4.237228
GSM537386patient 057, cancer, LCM [OPG study]4.0595123
GSM537398patient 094, cancer, LCM [OPG study]4.2095427
GSM537402patient 109, cancer, LCM [OPG study]4.2245527
GSM537405patient 130, cancer, LCM [OPG study]4.070923
GSM537371patient 023, cancer, LCM [OPG study]4.3660330
GSM537421patient 055, cancer, LCM [OPG study]4.2037527
GSM537424patient 065, cancer, LCM [OPG study]4.3886431
GSM537432patient 097, cancer, LCM [OPG study]4.2417528
GSM537331patient 100, cancer, LCM [OPG study]4.0905124
GSM537332patient 101, cancer, LCM [OPG study]4.1558227
GSM537334patient 103, cancer, LCM [OPG study]4.1944126
GSM537338patient 110, cancer, LCM [OPG study]4.3741431
GSM537353patient 135, cancer, LCM [OPG study]4.2438929
GSM537357patient 142, cancer, LCM [OPG study]4.5465835
GSM537358patient 143, cancer, LCM [OPG study]4.367131
GSM537375patient 030, cancer, LCM [OPG study]4.3634730
GSM537389patient 068, cancer, LCM [OPG study]4.4794635
GSM537390patient 072, cancer, LCM [OPG study]4.5760236
GSM537393patient 078, cancer, LCM [OPG study]4.1582627
GSM537399patient 095, cancer, LCM [OPG study]4.1716626
GSM537407patient 133, cancer, LCM [OPG study]4.7306137
GSM537408patient 140, cancer, LCM [OPG study]4.6711637
GSM537428patient 086, cancer, LCM [OPG study]4.3187329
GSM537354patient 136, cancer, LCM [OPG study]4.7325639
GSM537410patient 146, cancer, LCM [OPG study]4.4164531
GSM537413patient 027, cancer, LCM [OPG study]4.7180839
GSM537396patient 083, cancer, LCM [OPG study]4.1768127
GSM537397patient 088, cancer, LCM [OPG study]4.2611729
GSM537330patient 006, cancer, LCM [OPG study]4.3474430
GSM537369patient 015, cancer, LCM [OPG study]4.0430424
GSM537373patient 025, cancer, LCM [OPG study]4.7491638
GSM537401patient 106, cancer, LCM [OPG study]4.4685332
GSM537343patient 117, cancer, LCM [OPG study]4.3164730
GSM537367patient 155, cancer, LCM [OPG study]4.5113633
GSM537382patient 041, cancer, LCM [OPG study]4.2576828
GSM537385patient 053, cancer, LCM [OPG study]4.3947831
GSM537391patient 073, cancer, LCM [OPG study]4.2800729
GSM537419patient 045, cancer, LCM [OPG study]4.5356934
GSM537420patient 052, cancer, LCM [OPG study]4.2296727
GSM537429patient 089, cancer, LCM [OPG study]4.2744130
GSM537431patient 096, cancer, LCM [OPG study]4.3295428
GSM537387patient 061, cancer, LCM [OPG study]4.6269137
GSM537414patient 028, cancer, LCM [OPG study]4.4173132
GSM537433patient 098, cancer, LCM [OPG study]4.6349736
GSM537335patient 104, cancer, LCM [OPG study]4.2957830
GSM537339patient 111, cancer, LCM [OPG study]4.3546532
GSM537340patient 113, cancer, LCM [OPG study]4.7414838
GSM537344patient 118, cancer, LCM [OPG study]4.2952629
GSM537346patient 011, cancer, LCM [OPG study]4.2897229
GSM537351patient 128, cancer, LCM [OPG study]4.5267434
GSM537352patient 134, cancer, LCM [OPG study]4.5419235
GSM537359patient 144, cancer, LCM [OPG study]4.3943930
GSM537360patient 145, cancer, LCM [OPG study]4.3474131
GSM537364patient 152, cancer, LCM [OPG study]4.6028435
GSM537365patient 153, cancer, LCM [OPG study]4.1518726
GSM537372patient 024, cancer, LCM [OPG study]4.4370231
GSM537384patient 048, cancer, LCM [OPG study]4.4129331
GSM537394patient 081, cancer, LCM [OPG study]3.8927720
GSM537403patient 121, cancer, LCM [OPG study]4.6137635
GSM537406patient 131, cancer, LCM [OPG study]4.4380832
GSM537411patient 149, cancer, LCM [OPG study]4.3384928
GSM537412patient 019, cancer, LCM [OPG study]4.6262935
GSM537416patient 035, cancer, LCM [OPG study]4.3380731
GSM537426patient 079, cancer, LCM [OPG study]5.0720945